Back to Journals » OncoTargets and Therapy » Volume 13

Review

Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab

       
Total article views   HTML views PDF downloads Totals
6,880 Dovepress* 6,100+ 979 7,079
PubMed Central* 780 228 1,008
Totals 6,880 1,207 8,087
*Since 13 May 2020

View citations on PubMed Central and Google Scholar